PCNA and COVID-19: Several autoantibodies, including Ribosomal P (p = 0.05), SSA/Ro52 (p = 0.094) and PCNA (p = 0.154), showed modestly elevated median values in COVID‐19 samples compared to controls; however, only Ribosomal P reached statistical significance.